ACADIA Pharmaceuticals
ACAD · NASDAQ
Bulios Fair Price
$19.87
28.4% downside
Trenutna cena
$27.74
Po podatkih Bulios Fair Price je delnica ACAD trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
O podjetju
ACADIA Pharmaceuticals Inc. (ACAD) is an American biopharmaceutical company focusing on the development of innovative drugs for the treatment of central nervous system disorders. Their main product, pimavanserin, is an approved medication for the treatment of hallucinations and delusions associated with Parkinson's disease. ACADIA Pharmaceuticals actively engages in clinical trials and research to discover new therapeutic options for patients suffering from neurological disorders. ACADIA Pharmaceuticals Inc. (ACAD) shares could be suitable for investors looking to invest in the biopharmaceutical sector with a focus on innovative treatment approaches for neurological conditions.
V vašem jeziku še ni na voljo, zato je besedilo v angleščini.
Sector
Healthcare
Industry
Biotechnology
CEO
Catherine E. Owen Adams
Employees
797
Headquarters
San Diego
Prihajajoči dogodki
Earnings
Upcoming earnings report